Adimmune Corp. | |
Stock Exchange | Taiwan Stock Exchange |
EPS |
TWD2.53 |
Market Cap |
TWD8.37 T |
Shares Outstanding |
362.35 M |
Public Float |
- |
Address |
No. 3, Sec. 1, Tanxing Road Taichung TX 427 23 Taiwan |
Employees | - |
Website | http://www.adimmune.com.tw |
Updated | 07/08/2019 |
Adimmune Corp. engages in the development, manufacture, and distribution of human vaccine. Its products include seasonal influenza vaccine, Japanese encephalitis vaccine, and tetanus toxoid alum precipitated. The company also provides fill and finish services, testing/analysis services, quality assurance courses, and consulting services. |